ORIGINAL ARTICLE

Hypoparathyroidism and 22q11 deletion syndrome

S C Taylor¹, G Morris², D Wilson¹, S J Davies², J W Gregory²

¹ University Hospital of Wales, Cardiff and the Vale NHS Trust, Cardiff, UK
² University of Wales College of Medicine, Cardiff, UK

Correspondence to:
Correspondence to:
Dr J W Gregory, Department of Child Health, University of Wales College of Medicine, Cardiff CF14 4XN, UK;
gregoryjw{at}cardiff.ac.uk

Aims: To investigate a population of individuals with 22q11 deletion syndrome for hypocalcaemia.

Methods: A detailed clinical history enquiring into symptoms of hypocalcaemia and blood sampling to assess for hypocalcaemia and hypoparathyroidism, of patients outside the neonatal period known to have the 22q11 microdeletion from fluorescent in situ hybridisation studies was taken.

Results: Sixty one individuals were identified, of whom 23 were untraceable and one was unable to give informed consent. Biochemical investigations were performed on 27 subjects. Ten subjects had review of notes only. Four subjects had previously identified hypoparathyroidism. A new case of hypoparathyroidism was identified. Three subjects had borderline hypocalcaemia.

Discussion: In this population of patients with 22q11 deletion syndrome, 13% of the total or 30% of those biochemically assessed had evidence of reduced serum calcium concentrations. It is likely that 13–30% of patients with 22q11 deletion syndrome have possible hypoparathyroidism outside the neonatal period. Reported symptoms of hypocalcaemia did not correlate with biochemical evidence of persisting hypocalcaemia. We have shown that previously undiagnosed asymptomatic hypoparathyroidism occurs in patients with 22q11 deletion syndrome and conclude that screening of this population should be considered.

Keywords: hypoparathyroidism; hypocalcaemia; 22q11 deletion syndrome

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Hieronimus, S., Bec-Roche, M., Pedeutour, F., Lambert, J. C., Wagner-Malher, K., Mas, J. C., Sadoul, J. L., Fenichel, P. (2006). The spectrum of parathyroid gland dysfunction associated with the microdeletion 22q11.. Eur J Endocrinol 155: 47-52 [Abstract] [Full Text]  
• Nucera, C., Vaccaro, M., Moleti, M., Priolo, C., Tortorella, G., Angioni, A., Ientile, R., Violi, M. A., Loda, M., Trimarchi, F., Vermiglio, F. (2006). Antiphospholipid Antibodies Syndrome Associated with Hyperhomocysteinemia Related to MTHFR Gene C677T and A1298C Heterozygous Mutations in a Young Man with Idiopathic Hypoparathyroidism (DiGeorge Syndrome). J. Clin. Endocrinol. Metab. 91: 2021-2026 [Abstract] [Full Text]  
• Maalouf, N. M., Sakhaee, K., Odvina, C. V. (2004). A Case of Chromosome 22q11 Deletion Syndrome Diagnosed in a 32-Year-Old Man with Hypoparathyroidism. J. Clin. Endocrinol. Metab. 89: 4817-4820 [Abstract] [Full Text]